Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Diagnosed With Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05812040
What this trial is testing

Clinical Value of Breast High-Resolution MR Ductography in Patients With Pathological Nipple Discharge

Who this might be right for
Breast NeoplasmsNipple Discharge
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 134
Testing effectiveness (Phase 2)Active Not RecruitingNCT03606577
What this trial is testing

An Intensive Program With Quadruplet Induction and Consolidation Plus Tandem Autologous Stem Cell Transplantation in Newly Diagnosed High Risk Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Nantes University Hospital 50
Very early researchEnded earlyNCT03361800
What this trial is testing

Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC

Who this might be right for
Breast CancerInvasive Breast CancerER-Negative PR-Negative HER2-Negative Breast Cancer
UNC Lineberger Comprehensive Cancer Center 5
Testing effectiveness (Phase 2)Looking for participantsNCT06387121
What this trial is testing

Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 53
Early research (Phase 1)Study completedNCT06095375
What this trial is testing

Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients

Who this might be right for
Glioblastoma, IDH-wildtypeMGMT-Methylated Glioblastoma
Istituto Oncologico Veneto IRCCS 21
Testing effectiveness (Phase 2)Ended earlyNCT00717275
What this trial is testing

Study of Temozolomide to Treat Newly Diagnosed Brain Metastases

Who this might be right for
Brain Metastases
University of Florida 3
Not applicableLooking for participantsNCT07820644
What this trial is testing

A Cohort Study (Risk Prediction of HCC in Patients With Chronic Liver Disease)

Who this might be right for
Liver Cancer (Primary and Metastatic)
Cai Qingxian 15,000
Testing effectiveness (Phase 2)Ended earlyNCT01005914
What this trial is testing

Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
OHSU Knight Cancer Institute 11
Large-scale testing (Phase 3)Study completedNCT01104584
What this trial is testing

Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)

Who this might be right for
Breast Cancer
Bayer 460
Testing effectiveness (Phase 2)UnknownNCT00028847
What this trial is testing

Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia

Who this might be right for
Leukemia
Commissie Voor Klinisch Toegepast Onderzoek 60
Not applicableLooking for participantsNCT05703126
What this trial is testing

Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML

Who this might be right for
Acute Myeloid Leukemia, AdultCardiotoxicityEndothelial Dysfunction
Samara State Medical University 100
Early research (Phase 1)Active Not RecruitingNCT04047706
What this trial is testing

Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Northwestern University 18
Not applicableNot Yet RecruitingNCT05822284
What this trial is testing

CtDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction Chemoimmunotherapy

Who this might be right for
Non-small Cell Lung Cancer
Second Xiangya Hospital of Central South University 50
Testing effectiveness (Phase 2)Study completedNCT01698801
What this trial is testing

Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 26
Testing effectiveness (Phase 2)Study completedNCT01250119
What this trial is testing

Assess the Incidence of EGFR Mutation in Patients With Newly Diagnosed Locally Advanced or Metastatic Non-Small Cell Lung Cancer in the UK, And of Tarceva (Erlotinib) as First-Line Therapy in EGFR Mutation Positive Patients.

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 688
Early research (Phase 1)Study completedNCT04134936
What this trial is testing

Phase Ib Study to Assess Safety and Preliminary Efficacy of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients With Newly Diagnosed DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma
MorphoSys AG 66
Not applicableStudy completedNCT01407744
What this trial is testing

Study of Tumor Samples From Patients With Ependymoma Treated on the Children's Oncology Group ACNS0121 Trial

Who this might be right for
Childhood Infratentorial EpendymomaChildhood Supratentorial EpendymomaNewly Diagnosed Childhood Ependymoma
Children's Oncology Group 80
Testing effectiveness (Phase 2)Looking for participantsNCT05664464
What this trial is testing

Glutamate Inhibitors in Glioblastoma

Who this might be right for
Glioblastoma
University of Zurich 120
Early research (Phase 1)Study completedNCT05698199
What this trial is testing

Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)

Who this might be right for
Glioblastoma
Immunomic Therapeutics, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT03717298
What this trial is testing

Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma

Who this might be right for
Adenocarcinoma of the PancreasPancreatic CancerAdvanced Cancer+6 more
Catalysis SL 30
Next Page